5X8Y image
Entry Detail
PDB ID:
5X8Y
Keywords:
Title:
A Mutation identified in Neonatal Microcephaly Destabilizes Zika Virus NS1 Assembly in vitro
Biological Source:
Source Organism:
Host Organism:
PDB Version:
Deposition Date:
2017-03-03
Release Date:
2017-05-17
Method Details:
Experimental Method:
Resolution:
2.82 Å
R-Value Free:
0.25
R-Value Work:
0.20
R-Value Observed:
0.21
Space Group:
C 2 2 21
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:ZIKV NS1
Chain IDs:A, B
Chain Length:185
Number of Molecules:2
Biological Source:Zika virus
Primary Citation
A Mutation Identified in Neonatal Microcephaly Destabilizes Zika Virus NS1 Assembly in Vitro
Sci Rep 7 42580 42580 (2017)
PMID: 28198446 DOI: 10.1038/srep42580

Abstact

An unprecedented epidemic of Zika virus (ZIKV) infection had spread to South and Central America. ZIKV infection was recently confirmed by CDC (the Centers for Disease Control and Prevention) to cause neonatal microcephaly, which posed a significant public health emergency of international concern. No specific vaccines or drugs are currently available to fight ZIKV infection. ZIKV nonstructural protein 1 (NS1) plays an essential role in viral replication and immune evasion. We determined the crystal structure of ZIKV NS1172-352, which forms a head-to-head, symmetric dimer with a unique 14-stranded β-ladder conserved among flaviviruses. The assembly of the β-ladder dimer is concentration dependent. Strikingly, one pathogenic mutation T233A (NCBI accession no. KU527068), found in the brain tissue of infected fetus with neonatal microcephaly, is located at the dimer interface. Thr233, a unique residue found in ZIKV but not in other flaviviruses, organizes a central hydrogen bonding network at NS1 dimer interface. Mutation of Thr233 to Ala disrupts this elaborated interaction network, and destabilizes the NS1 dimeric assembly in vitro. In addition, our structural comparison of epitopes for protective antibody 22NS1, targeting West Nile Virus NS1, could potentially be valuable in understanding its anti-virus specificities and in the development of antibodies against ZIKV.

Legend

Protein

Chemical

Disease

Primary Citation of related structures